| Axon ID |
Name |
Description |
From price |
|
1243
|
NSC 625987
|
CDK4 inhibitor |
€95.00 |
|
1505
|
PD0332991 hydrochloride
|
CDK4 and CDK6 inhibitor |
€80.00 |
|
1530
|
RO 3306
|
CDK1 inhibitor |
€80.00 |
|
1539
|
AT 7519 mesylate
|
CDK inhibitor |
€80.00 |
|
1614
|
SNS 032
|
CDK inhibitor (2, 7 and 9 specific) |
€85.00 |
|
1966
|
AZD5438
|
CDK inhibitor (1, 2, and 9 specific) |
€80.00 |
|
1983
|
R 547
|
CDK inhibitor (1, 2, and 4 specific) |
€95.00 |
|
2052
|
Palbociclib isethionate
|
Orally active cyclin-dependent kinase (CDK4/6) inhibitor |
€125.00 |
|
2268
|
XL 413 hydrochloride
|
Potent, selective and orally bioavailable CDC7 inhibitor |
€120.00 |
|
2273
|
LEE 011
|
Orally bioavailable and highly selective small-molecule inhibitor of CDK4/6 |
€70.00 |
|
2695
|
NSC 23005 sodium
|
Novel small molecule inhibitor of INK4C (p18(INK4C) or p18) |
€90.00 |
|
2690
|
PHA-767491
|
Dual CDC7/CDK9 kinase inhibitor |
€95.00 |
|
3184
|
SR-4835
|
Potent, highly selective and orally bioavailable dual CDK12/CDK13 inhibitor |
€130.00 |
|
3228
|
CDK inhibitor CR8
|
Potent CDK inhibitor (1, 2, 5, 7, and 9 specific) |
€130.00 |
|
3402
|
THZ531
|
First-in-class, potent, selective, covalent CDK12/CDK13 inhibitor |
€130.00 |
|
3693
|
PF-06873600
|
CDK inhibitor (4, 6, and 8 specific) |
Inquire |
|
3753
|
PF-07104091
|
Specific CDK2 inhibitor |
€140.00 |
|
3762
|
PF-07220060
|
Orally bioavailable and CDK4-Specific Inhibitor |
Inquire |
|
3800
|
AZD4573
|
Inhibitor of CDK9 |
Inquire |
|
3801
|
Voruciclib
|
Inhibitor of CDK9 |
Inquire |
|
3876
|
OTS-964
|
TOPK (T–lymphokine-activated killer cell–originated protein kinase) inhibitor |
Inquire |
|
3935
|
BAY-1251152
|
Potent and highly selective CDK9/P-TEFb inhibitor |
Inquire |
|
4071
|
AMG-925
|
Potent, selective, and orally available FLT3/CDK4 dual inhibitor |
Inquire |
|
4097
|
OTS964 hydrochloride
|
TOPK (T–lymphokine-activated killer cell–originated protein kinase) inhibitor |
€120.00 |
|
3525
|
ETP-47799
|
Potent CDK8/CDK19 inhibitor |
€90.00 |